Apr 29, 2015 – FDA Accepts BLA for Zinbryta (Daclizumab High-Yield Process) for Treatment of MS. FDA Accepts BLA for Zinbryta (Daclizumab High-Yield Process) for Treatment of MS.
Apr 29, 2015 – FDA Accepts BLA for Zinbryta (Daclizumab High-Yield Process) for Treatment of MS. FDA Accepts BLA for Zinbryta (Daclizumab High-Yield Process) for Treatment of MS.